Sotera Health Company SHC
Analyst Consensus
Price Objectif
Analyst historical
| Analyste | Entreprise | Prix lors de l'analyse | Prix cible | Gain potentiel | Date de publication |
|---|---|---|---|---|---|
| Matthew Sykes | Goldman Sachs | 12.92 $ | 17 $ | 4.08 % | 05/05/2025 |
| David Windley | Jefferies | 12.98 $ | 15 $ | 2.02 % | 05/12/2024 |
| David Windley | Jefferies | 15.27 $ | 18 $ | 2.73 % | 06/11/2024 |
| Luke Sergott | Barclays | 14.22 $ | 17 $ | 2.78 % | 06/08/2024 |
| David Windley | Jefferies | 11.98 $ | 14.5 $ | 2.52 % | 06/06/2024 |
| Jason Bednar | Piper Sandler | 10.91 $ | 13 $ | 2.09 % | 21/05/2024 |
| Sean Dodge | RBC Capital | 10.91 $ | 17 $ | 6.09 % | 03/05/2024 |
| Luke Sergott | Barclays | 11.62 $ | 14 $ | 2.38 % | 10/04/2024 |
| David Windley | Jefferies | 11.935 $ | 15.5 $ | 3.57 % | 25/03/2024 |
| Matthew Mishan | Loop Capital Markets | 18.585 $ | 24 $ | 5.42 % | 26/06/2023 |
| Mike Polark | Wolfe Research | 17.25 $ | 25 $ | 7.75 % | 10/01/2023 |
| Luke Sergott | Barclays | 17.25 $ | 22 $ | 4.75 % | 10/01/2023 |